CytomX Therapeutics - 51 Year Dividend History | CTMX

Historical dividend payout and yield for CytomX Therapeutics (CTMX) since 1971. The current TTM dividend payout for CytomX Therapeutics (CTMX) as of January 20, 2022 is $0.00. The current dividend yield for CytomX Therapeutics as of January 20, 2022 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.266B $0.100B
CytomX Therapeutics, Inc. is an oncology focused biopharmaceutical company. The Company is engaged in developing Probody(TM) therapeutics for the treatment of cancer. Its pipeline focuses areas consist of Precision cancer immunotherapy and Probody drug conjugates. CytomX Therapeutics, Inc. is headquartered in South San Francisco, California.
Stock Name Country Market Cap PE Ratio